Aptevo Therapeutics Inc. (NASDAQ: APVO)
$0.31
-0.0079 ( -2.52% ) 1.2M
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
Market Data
Open
$0.31
Previous close
$0.31
Volume
1.2M
Market cap
$1.25M
Day range
$0.29 - $0.33
52 week range
$0.28 - $64.90
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
10-k | Annual reports | 97 | Mar 05, 2024 |
8-k | 8K-related | 12 | Feb 06, 2024 |
4 | Insider transactions | 1 | Jan 30, 2024 |
4 | Insider transactions | 1 | Jan 30, 2024 |
4 | Insider transactions | 1 | Jan 30, 2024 |
def | Proxies and info statements | 4 | Dec 22, 2023 |
pre | Proxies and info statements | 4 | Dec 12, 2023 |